Advertisement

CDC National Call Series on Novel Coronavirus Monitoring & Preparedness

The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national

The Novel Coronavirus: What Do We Know and What’s Next?

Neuroscience Research Building (NRB) 635 Charles E Young Drive South, Los Angeles, CA, United States

The UCLA Fielding School of Public Health and the UCLA Center for Chinese Studies present The Novel Coronavirus: What Do We Know and What's Next?, a symposium and reception. The novel coronavirus (2019-nCoV) was first reported in Wuhan, China in December 2019. On January 30, 2020, the WHO declared the outbreak a public health emergency of

WHO Global Research and Innovation Forum: 2019-nCoV Emergency

WHO Headquarters Geneva, Switzerland

The World Health Organization will host a Global research and innovation forum 11-12 February in Geneva to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency. The event is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R), and brings together key players including leading scientists as well as

Homeland Security & Governmental Affairs Committee: Protecting the U.S. from Global Pandemics

Dirksen Senate Office Building Washington, DC, United States

The U.S. Senate Committee on Homeland Security & Governemental Affairs will convene a Full Committee hearing on Feb.12 to examine protecting the United States from global pandemics. ROUNDTABLE: Are We Prepared? Protecting the U.S. from Global Pandemics will February 12, 2020 09:30 AM Location: SD-G50, Dirksen Senate Office Building The meeting will air on CSPAN. See

Deadline: CEPI Call for Proposals – Vaccines Against Novel Coronavirus

Global Biodefense Calendar

CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. The call is open for two weeks until mid-February. Applications are open worldwide to all types of non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and

Public Health Emergency Preparedness (PHEP) Monthly Call

PHEP Recipient Monthly Conference Call Scheduled for February 19 CDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday, February 19. Participant information is provided below.   Conference Call Information Bridge Line: (888) 566-1873 Participant Code: 3358383   The Public Health Emergency Preparedness (PHEP) cooperative

2019-nCoV Update for Health Care Providers

Hastings Prince Edward Public Health 179 North Park Street, Belleville, ON, Canada

Target Audience: Health care providers (including primary care physicians & nursing professionals) Key Note Speakers: Dr. Gerald Evans Chair of the Division of Infectious Diseases, Professor of Medicine, Queens University; Attending Staff, Kingston Health Sciences Centre Dr. Piotr Oglaza Medical Officer of Health & CEO, Hastings Prince Edward Public Health Yvonne DeWit, Epidemiologist, Hastings Prince

DARPA BTO BAA Deadline: Personalized Protective Biosystems

Global Biodefense Calendar

The capability to provide unburdened chem-bio protection will maximize time on target for the warfighter and the stability operator, provide operational flexibility, extend mission duration, and enable military operations in austere environments regardless of the threat. PPB will consist of lightweight materials that protect the warfighter from exposure to any CB threat while simultaneously providing

CDC National Call Series on Novel Coronavirus Monitoring & Preparedness

The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national